These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29613847)

  • 21. Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM: Comparison With CMR T1-Mapping and Histology in a Rabbit Model.
    Hong YJ; Kim TK; Hong D; Park CH; Yoo SJ; Wickum ME; Hur J; Lee HJ; Kim YJ; Suh YJ; Greiser A; Paek MY; Choi BW
    JACC Cardiovasc Imaging; 2016 Jul; 9(7):836-845. PubMed ID: 27236517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of myocardial involvement by T
    Yu L; Sun J; Sun J; Li J; Dong Y; Zhou X; Greiser A; Han Y; Zhang Q; Xie Q; Chen Y
    J Magn Reson Imaging; 2018 Aug; 48(2):415-422. PubMed ID: 29328539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose correction for post-contrast T1 mapping of the heart: the MESA study.
    Gai ND; Sandfort V; Liu S; Lima JAC; Bluemke DA
    Int J Cardiovasc Imaging; 2016 Feb; 32(2):271-279. PubMed ID: 26362875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in remote myocardial tissue after acute myocardial infarction and its relation to cardiac remodeling: A CMR T1 mapping study.
    Biesbroek PS; Amier RP; Teunissen PFA; Hofman MBM; Robbers LFHJ; van de Ven PM; Beek AM; van Rossum AC; van Royen N; Nijveldt R
    PLoS One; 2017; 12(6):e0180115. PubMed ID: 28644903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A feasible and automatic free tool for T1 and ECV mapping.
    Altabella L; Borrazzo C; Carnì M; Galea N; Francone M; Fiorelli A; Di Castro E; Catalano C; Carbone I
    Phys Med; 2017 Jan; 33():47-55. PubMed ID: 28003137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular volume fractions in chronic myocardial infarction.
    Bauner KU; Biffar A; Theisen D; Greiser A; Zech CJ; Nguyen ET; Reiser MF; Wintersperger BJ
    Invest Radiol; 2012 Sep; 47(9):538-45. PubMed ID: 22836311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of denoising on precision and accuracy of saturation-recovery-based myocardial T
    Bustin A; Ferry P; Codreanu A; Beaumont M; Liu S; Burschka D; Felblinger J; Brau ACS; Menini A; Odille F
    J Magn Reson Imaging; 2017 Nov; 46(5):1377-1388. PubMed ID: 28376285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Structure-Function MRI in Patients After Heart Transplantation.
    Dolan RS; Rahsepar AA; Blaisdell J; Lin K; Suwa K; Ghafourian K; Wilcox JE; Khan SS; Vorovich EE; Rich JD; Anderson AS; Yancy CW; Collins JD; Markl M; Carr JC
    J Magn Reson Imaging; 2019 Mar; 49(3):678-687. PubMed ID: 30142237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Early Diffuse Myocardial Fibrosis and Inflammation in Chagas Cardiomyopathy with T1 Mapping and Extracellular Volume.
    Melo RJL; Assunção AN; Morais TC; Nomura CH; Scanavacca MI; Martinelli-Filho M; Ramires FJA; Fernandes F; Ianni BM; Mady C; Rochitte CE
    Radiol Cardiothorac Imaging; 2023 Jun; 5(3):e220112. PubMed ID: 37404789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy.
    Karur GR; Robison S; Iwanochko RM; Morel CF; Crean AM; Thavendiranathan P; Nguyen ET; Mathur S; Wasim S; Hanneman K
    Radiology; 2018 Aug; 288(2):398-406. PubMed ID: 29688154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of native and contrast-enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques.
    Nadjiri J; Nieberler H; Hendrich E; Greiser A; Will A; Martinoff S; Hadamitzky M
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):539-547. PubMed ID: 27878700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of age, gender, and risk-factors for heart failure on native myocardial T
    Pagano JJ; Chow K; Paterson DI; Mikami Y; Schmidt A; Howarth A; White J; Friedrich MG; Oudit GY; Ezekowitz J; Dyck J; Thompson RB
    J Magn Reson Imaging; 2018 Nov; 48(5):1307-1317. PubMed ID: 29897656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T1 mapping in children and young adults with hypertrophic cardiomyopathy.
    Parekh K; Markl M; Deng J; de Freitas RA; Rigsby CK
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):109-117. PubMed ID: 27659477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T1, T2, and Fat Fraction Cardiac MR Fingerprinting: Preliminary Clinical Evaluation.
    Jaubert O; Cruz G; Bustin A; Hajhosseiny R; Nazir S; Schneider T; Koken P; Doneva M; Rueckert D; Masci PG; Botnar RM; Prieto C
    J Magn Reson Imaging; 2021 Apr; 53(4):1253-1265. PubMed ID: 33124081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left Ventricular Myocardial Fibrosis, Atrophy, and Impaired Contractility in Patients With Pulmonary Arterial Hypertension and a Preserved Left Ventricular Function: A Cardiac Magnetic Resonance Study.
    Homsi R; Luetkens JA; Skowasch D; Pizarro C; Sprinkart AM; Gieseke J; Meyer Zur Heide Gen Meyer-Arend J; Schild HH; Naehle CP
    J Thorac Imaging; 2017 Jan; 32(1):36-42. PubMed ID: 27861208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of myocardial extracellular volume fraction in heart failure patients using iodine map with rapid-kV switching dual-energy CT: Segmental comparison with MRI T1 mapping.
    Ohta Y; Kishimoto J; Kitao S; Yunaga H; Mukai-Yatagai N; Fujii S; Yamamoto K; Fukuda T; Ogawa T
    J Cardiovasc Comput Tomogr; 2020; 14(4):349-355. PubMed ID: 31892473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.